Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Molecular Therapy - Methods and Clinical Development
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(13)
+
-
Availability
Open access
(13)
+
-
Metadata Only
(1)
+
-
Creation Date
2019
(4)
+
-
2021
(3)
+
-
2023
(3)
+
-
2020
(2)
+
-
Faculty
Faculty of Science
(1)
+
-
Leiden University Medical Center (LUMC)
(10)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(10)
+
-
Scholarly Publications
(3)
+
-
Author
Deventer, S.J. van
(4)
+
-
Evers, M.M.
(4)
+
-
Konstantinova, P.
(4)
+
-
Brouwers, C.C.
(2)
+
-
Cavazzana, M.
(2)
+
-
Depla, J.A.
(2)
+
-
Haan, M. de
(2)
+
-
Keskin, S.
(2)
+
-
Martier, R.
(2)
+
-
Meij, P.
(2)
+
-
Petry, H.
(2)
+
-
Pike-Overzet, K.
(2)
+
-
Rothe, M.
(2)
+
-
Schambach, A.
(2)
+
-
Sogorb Gonzalez, M.
(2)
+
-
Spronck, E.A.
(2)
+
-
Staal, F.J.T.
(2)
+
-
Valles, A.
(2)
+
-
Wijnholds, J.
(2)
+
-
Show more
Language
en
(14)
+
-
Search results
(1 - 14 of 14)
show grid
show list
save search
Characterization and AAV-mediated CRB gene augmentation in human-derived CRB1KO and CRB1KOCRB2+/- retinal organoids
Tagged IDS causes efficient and engraftment- independent prevention of brain pathology during lentiviral gene therapy for Mucopolysaccharidosis type II
Human iPSC-derived preclinical models to identify toxicity of tumor-specific T cells with clinical potential
Evidence generation and reproducibility in cell and gene therapy research: a call to action
Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector
AAV-CRB2 protects against vision loss in an inducible CRB1 retinitis pigmentosa mouse model
Cerebral organoids
Successful preclinical development of gene therapy for recombinase-activating gene-1-deficient SCID
Enhanced factor IX activity following administration of AAV5-R338L "Padua" factor IX versus AAV5 WT human factor IX in NHPs
AAV5-miHTT lowers huntingtin mRNA and protein without off-target effects in patient-derived neuronal cultures and astrocytes
Development of an AAV-based microRNA gene therapy to treat Machado-Joseph disease
AAV5-miHTT gene therapy demonstrates sustained Huntingtin lowering and functional improvement in Huntington disease mouse models
Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis
Clinical development of gene- and cell-based therapies: overview of the European landscape